Your browser doesn't support javascript.
loading
Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study.
Willemse, Eline A J; De Vos, Ann; Herries, Elizabeth M; Andreasson, Ulf; Engelborghs, Sebastiaan; van der Flier, Wiesje M; Scheltens, Philip; Crimmins, Dan; Ladenson, Jack H; Vanmechelen, Eugeen; Zetterberg, Henrik; Fagan, Anne M; Blennow, Kaj; Bjerke, Maria; Teunissen, Charlotte E.
Afiliación
  • Willemse EAJ; Neurochemistry laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, VU University Medical Center Amsterdam, the Netherlands; e.willemse@vumc.nl.
  • De Vos A; Alzheimer Center, Department of Neurology, Amsterdam Neuroscience, VU University Medical Center Amsterdam, the Netherlands.
  • Herries EM; Reference Center for Biological Markers of Dementia (BIODEM), Department of Biomedical Sciences, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
  • Andreasson U; ADx NeuroSciences, Ghent, Belgium.
  • Engelborghs S; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.
  • van der Flier WM; Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
  • Scheltens P; Reference Center for Biological Markers of Dementia (BIODEM), Department of Biomedical Sciences, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
  • Crimmins D; Alzheimer Center, Department of Neurology, Amsterdam Neuroscience, VU University Medical Center Amsterdam, the Netherlands.
  • Ladenson JH; VU University Medical Center, Epidemiology & Biostatistics, Amsterdam, the Netherlands.
  • Vanmechelen E; Alzheimer Center, Department of Neurology, Amsterdam Neuroscience, VU University Medical Center Amsterdam, the Netherlands.
  • Zetterberg H; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.
  • Fagan AM; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.
  • Blennow K; ADx NeuroSciences, Ghent, Belgium.
  • Bjerke M; Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
  • Teunissen CE; UCL Institute of Neurology, Department of Molecular Neuroscience, Queen Square, London, United Kingdom.
Clin Chem ; 64(6): 927-937, 2018 06.
Article en En | MEDLINE | ID: mdl-29523639
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biomarcadores / Líquido Cefalorraquídeo / Neurogranina / Enfermedad de Alzheimer Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Chem Asunto de la revista: QUIMICA CLINICA Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biomarcadores / Líquido Cefalorraquídeo / Neurogranina / Enfermedad de Alzheimer Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Chem Asunto de la revista: QUIMICA CLINICA Año: 2018 Tipo del documento: Article